Latest Oncopeptides News & Updates

See the latest news and media coverage for Oncopeptides. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Oncopeptides

Biotech developing therapies for difficult-to-treat cancers

oncopeptides.com
Headquarters
Stockholm, Sweden
Founded year
2000
Company type
Public company
Number of employees
70–200
Industry
Pharmaceuticals

Last updated

Latest news about Oncopeptides

In short: Oncopeptides achieved significant sales growth, expanded Pepaxti's European reach, and launched its first clinical trial for glioblastoma.

Company announcements

Oncopeptides

Oncopeptides enrolls first patient in MARINA study in Germany

The investigator-initiated study evaluates Pepaxti with dexamethasone for multiple myeloma in routine clinical settings in Germany.

Unlock all announcements with a

Media coverage

Life Science Sweden

Kick-off for Oncopeptides' clinical study in brain cancer

The study, which is being conducted at Oslo University Hospital, will evaluate the company's proprietary platform for peptide-drug conjugates (PDC) in a total of about ten patients with glioblastoma, which is an aggressive...

Yahoo Finance

Oncopeptides AB (FRA:OND) Q1 2026 Earnings Call Highlights: Strong Sales Growth...

This article first appeared on GuruFocus. Release Date: May 13, 2026 For the complete transcript of the earnings call, please refer to the full earnings...

Unlock all articles with a

Never miss news about Oncopeptides

Track Oncopeptides and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Oncopeptides competitors & trending companies

Browse news for competitors to Oncopeptides and other trending companies.